Published in Acad Radiol on February 01, 1999
Contrast-enhanced MR imaging of lymph nodes in cancer patients. Korean J Radiol (2010) 0.81
Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base. Pharmacogenomics J (2001) 5.94
Mussels and Clams: A Seasonal Quarantine-Bicarbonate of Soda as a Factor in the Prevention of Mussel Poisoning. Cal West Med (1932) 2.02
BioPortal: ontologies and data resources with the click of a mouse. AMIA Annu Symp Proc (2008) 1.54
The cyclin B2 promoter depends on NF-Y, a trimer whose CCAAT-binding activity is cell-cycle regulated. Oncogene (1999) 1.47
Genome-wide association study of Tourette's syndrome. Mol Psychiatry (2012) 1.42
Ring 10 chromosome: 46,XX,r10(p15q26). Hum Genet (1978) 1.37
Prospective randomized multicentre trial of proximal gastric vagotomy or truncal vagotomy and antrectomy for chronic duodenal ulcer: interim results. Br J Surg (1978) 1.31
Targeting adolescent risk-taking behaviors: the contributions of egocentrism and sensation-seeking. J Adolesc (2000) 1.31
Analysis of altered gene expression by differential display. Methods Enzymol (1995) 1.29
Low-dose subcutaneous heparin versus oral anticoagulants in the prevention of postoperative deep-venous thrombosis. A controlled clinical trial. Lancet (1974) 1.24
Causes of failure in the surgical treatment of primary hyperparathyroidism: lessons from 51 successful reoperations. Br J Surg (1978) 1.24
The frequency of trisomy and translocation in Down's syndrome. J Pediatr (1967) 1.23
Cloning and characterization of actin depolymerizing factor from Toxoplasma gondii. Mol Biochem Parasitol (1997) 1.19
Retinoblastoma with 13q- chromosomal deletion associated with maternal paracentric inversion of 13q. Science (1979) 1.18
The prevalence of diffuse idiopathic skeletal hyperostosis in African blacks. Br J Rheumatol (1990) 1.07
Xeroderma pigmentosum-Cockayne syndrome complex in two patients: absence of skin tumors despite severe deficiency of DNA excision repair. J Am Acad Dermatol (1993) 1.07
Ring 11 chromosome (46,xx,r11(p15q25)). Hum Genet (1977) 1.01
The AN2 protein is a novel marker for the Schwann cell lineage expressed by immature and nonmyelinating Schwann cells. J Neurosci (2001) 0.97
Formative evaluation of ontology learning methods for entity discovery by using existing ontologies as reference standards. Methods Inf Med (2013) 0.95
Sex, age, and hyperparathyroidism. Lancet (1969) 0.95
Safety and efficacy of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. multicenter phase III clinical trials (safety). J Magn Reson Imaging (2000) 0.93
True recurrence of hyperparathyroidism: proposed criteria of recurrence. Br J Surg (1975) 0.93
Identification and characterization of a differentiation-specific antigen on normal and malignant murine erythroid cells. Blood (1987) 0.92
Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging. J Magn Reson Imaging (2000) 0.92
Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties. Bioconjug Chem (1999) 0.92
An unexpected complication of a liver biopsy. Br J Surg (1977) 0.91
Differentiation of liver hemangiomas from metastases and hepatocellular carcinoma at MR imaging enhanced with blood-pool contrast agent Code-7227. Radiology (1997) 0.89
Cervical spine fracture in diffuse idiopathic skeletal hyperostosis. J Rheumatol (1988) 0.88
Dynamics of tumor imaging with Gd-DTPA-polyethylene glycol polymers: dependence on molecular weight. J Magn Reson Imaging (1994) 0.87
1,3,5-Trialkyl-2,4,6-triiodobenzenes: novel X-ray contrast agents for gastrointestinal imaging. J Med Chem (2000) 0.87
A NADH-dependent transketolase assay in erythrocyte hemolysates. Clin Chim Acta (1971) 0.87
A multisite phase III study of the safety and efficacy of a new manganese chloride-based gastrointestinal contrast agent for MRI of the abdomen and pelvis. J Magn Reson Imaging (1999) 0.86
Pharmacokinetics and hepatic disposition of bis[1-(ethoxycarbonyl)propyl]5-acetylamino-2,4,6-triiodoisophthalate in rats and isolated perfused rat livers. Drug Metab Dispos (2000) 0.86
Double monosomy mosaicism (45,X-45, XX,21-) in a retarded child with multiple congenital malformations. Cytogenetics (1971) 0.86
Dynamic contrast-enhanced MRI of Implanted VX2 tumors in rabbit muscle: comparison of Gd-DTPA and NMS60. Magn Reson Imaging (1999) 0.84
Structural and biological characteristics of reoviruses isolated from Muscovy ducks (Cairina moschata). Avian Pathol (1992) 0.83
Studies on the association of NAD glycohydrolase with membranes in calf spleen. Eur J Biochem (1980) 0.83
Novel and potent adenosine 3',5'-cyclic phosphate phosphodiesterase III inhibitors: thiazolo[4,5-b][1,6]naphthyridin-2-ones. J Med Chem (1995) 0.82
The effect of proflavin in yeast cells. Biochim Biophys Acta (1968) 0.82
Down's syndrome with 47,XX,+21-47,XX,+mar mosaicism. J Med Genet (1973) 0.82
CT imaging of intrathoracic lymph nodes in dogs with bronchoscopically administered iodinated nanoparticles. Acad Radiol (1999) 0.82
Synthesis and structure-activity relationships of 6-heterocyclic-substituted purines as inactivation modifiers of cardiac sodium channels. J Med Chem (1995) 0.81
Blood pool and liver enhancement in CT with liposomal lodixanol: comparison with lohexol. Acad Radiol (1999) 0.81
Calf spleen NAD glycohydrolase. Comparison of the catalytic properties of the membrane-bound and the hydrosoluble forms of the enzyme. Eur J Biochem (1979) 0.80
Insulin-like growth factor binding proteins and their regulation. Acta Paediatr Suppl (1994) 0.80
Amphipathic properties of calf spleen NAD glycohydrolase. FEBS Lett (1980) 0.80
A female patient with the Rothmund-Thomson syndrome associated with anhidrosis and severe infections of the respiratory tract. Dermatology (1998) 0.80
Pulmonary delivery of nanoparticles of insoluble, iodinated CT X-ray contrast agents to lung draining lymph nodes in dogs. J Pharm Sci (1998) 0.80
Novel cAMP PDE III inhibitors: imidazo[4,5-b]pyridin-2(3H)-ones and thiazolo[4,5-b]pyridin-2(3H)-ones and their analogs. J Med Chem (1994) 0.80
Lymph node extraction of radiopaque nanoparticulates in the rabbit as measured in vivo with CT. Acad Radiol (1999) 0.79
3-Quinolinecarboxamides. A series of novel orally-active antiherpetic agents. J Med Chem (1993) 0.79
Transient catecholamine modulation of neutrophil activation: kinetic and intracellular aspects of isoproterenol action. J Leukoc Biol (1986) 0.79
A narrow and highly significant linkage signal for severe bipolar disorder in the chromosome 5q33 region in Latin American pedigrees. Am J Med Genet B Neuropsychiatr Genet (2009) 0.79
Detection of hepatic malignancies using Mn-DPDP (manganese dipyridoxal diphosphate) hepatobiliary MRI contrast agent. Magn Reson Imaging (1990) 0.79
Rapid identification of "very virulent" strains of infectious bursal disease virus by reverse transcription-polymerase chain reaction combined with restriction enzyme analysis. Avian Pathol (2001) 0.79
An experimental evaluation of central vs. peripheral injection for intravenous digital subtraction angiography (IV-DSA). Invest Radiol (1984) 0.78
Expression of putative anticancer targets in familial adenomatous polyposis and its association with the APC mutation status. Int J Oncol (2001) 0.78
Lymphoma and the nephrotic syndrome. S Afr Med J (1971) 0.78
Linburg syndrome. Can J Surg (1998) 0.77
Regulation of B cell lymphomagenesis by a malignant Qal+ inducer T cell clone. J Exp Med (1984) 0.77
Safety and efficacy of a new oral contrast agent for sonography: a phase II trial. AJR Am J Roentgenol (1999) 0.77
Amplification of granulopoiesis by T cell subpopulations. Exp Hematol (1983) 0.77
Quantitation of saturation effects versus dose in three-dimensional time-of-flight magnetic resonance angiography with blood-pool contrast agents. Invest Radiol (1994) 0.77
Time course of nodal enhancement with CT X-ray nanoparticle contrast agents: effect of particle size and chemical structure. Invest Radiol (2000) 0.77
Survey of cancer in children admitted to a Brazilian charity hospital. J Natl Cancer Inst (1969) 0.77
Long-term effect of irradiation on lymph node uptake of interstitially delivered nanoparticulate contrast media. Invest Radiol (2000) 0.76
Partial 4q duplication due to inherited der(20), t(4;20)(q25;q13)mat. Ann Genet (1977) 0.76
A sonographic assessment of neonatal renal parameters. J Ultrasound Med (1985) 0.75
Magnetic resonance imaging in patients with central nervous system pathology: a comparison of OptiMARK (Gd-DTPA-BMEA) and Magnevist (Gd-DTPA). Invest Radiol (2000) 0.75
Induction of fracture healing using fibrous calcium phosphate composite spherulites. Invest Radiol (1991) 0.75
The Zollinger-Ellison syndrome. Observations on eight patients. Neth J Med (1974) 0.75
Terrorism. Part III--Response procedures for terrorist/tactical violence incidents. JEMS (1999) 0.75
Terrorism. Part 1: Calibrating your risks and response. JEMS (1998) 0.75
Involvement of a cyclic-AMP pathway in group I metabotropic glutamate receptor responses in neonatal rat cortex. Eur J Pharmacol (1997) 0.75
MITOM: a new unfolding code based on a spectra model method applied to neutron spectrometry. Radiat Prot Dosimetry (2004) 0.75
T-cell regulation of erythropoiesis during acute lymphoblastic leukemia. Exp Hematol (1985) 0.75
Performance of the electronic personal dosemeter for neutron 'Saphydose-N' at different workplaces of nuclear facilities. Radiat Prot Dosimetry (2006) 0.75
Workplace characterisation in case of rail transport of radioactive materials. Radiat Prot Dosimetry (2006) 0.75
Strokes in the anterior circulation: comparison between bridging and intravenous thrombolysis. Acta Neurol Scand (2014) 0.75
Neutron spectrometry around the VENUS reactor using Monte Carlo simulations and Bonner spheres measurements. Radiat Prot Dosimetry (2007) 0.75
Characterisation of the IRSN CANEL/T400 facility producing realistic neutron fields for calibration and test purposes. Radiat Prot Dosimetry (2004) 0.75
Evaluation of individual monitoring in mixed neutron/photon fields: mid-term results from the EVIDOS project. Radiat Prot Dosimetry (2006) 0.75
Criticality accident dosimetry systems: an international intercomparison at the SILENE reactor in 2002. Radiat Prot Dosimetry (2004) 0.75
Reference dosimetry measurements for the international intercomparison of criticality accident dosimetry SILENE 9-21 June 2002. Radiat Prot Dosimetry (2004) 0.75
Set-up of a passive Bonner sphere system for neutron spectrometry at mixed fields with predominant photon component based on activation detector. Radiat Prot Dosimetry (2007) 0.75
Oral manifestation of cytomegalovirus associated with herpes simplex virus in renal transplant recipient. Transplant Proc (2008) 0.75
Bonner sphere neutron spectrometry at nuclear workplaces in the framework of the EVIDOS project. Radiat Prot Dosimetry (2007) 0.75
Monte Carlo calculations and validation of a gold foil-based Bonner sphere system. Radiat Prot Dosimetry (2007) 0.75
In vitro colony formation in bone marrow and spleen cell suspensions from rats with an acute myelogenous leukemia. J Lab Clin Med (1974) 0.75
Successful surgical treatment of ruptured abdominal aneurysm after twenty-two hours of controlled hypotension. Am J Surg (1973) 0.75
Primary cardiac lymphoma causing right atrial occlusion. Thorac Cardiovasc Surg (2011) 0.75
[Effects of Light Near-Infrared Radiation on Rats Assessed by Succinate Dehydrogenase Activity in Lymphocytes on Blood Smears]. Biofizika (2016) 0.75
Characterization of neutron field in a NPP workplace. Radiat Prot Dosimetry (2007) 0.75
Neutron measurements in the Vandellòs II nuclear power plant with a Bonner sphere system. Radiat Prot Dosimetry (2004) 0.75